This condition is termed chronic granulomatous disease (CGD) and is traceable to genetic disruptions of NADPH oxidase, i.e. in approximately 65% of cases to mutations of the Cybb gene encoding the cytochrome b-245 H chain catalytic subunit [5]. This evidence concerns the gene CYBB and chronic granulomatous disease.